Publication | Closed Access

Development of collagen–hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering

Tissue EngineeringEngineeringBone RepairBiofabricationBiomedical EngineeringOrthopaedic SurgeryRegenerative MedicineSynthetic Bone SubstituteRegenerative BiomaterialsMatrix BiologyAlginate MicroparticlesRegenerative EngineeringControlled DeliveryFunctional Tissue EngineeringCollagen–hydroxyapatite ScaffoldsHydroxyapatiteMedicineBiomaterialsBiocompatible Material